Vaccine Pharmacovigilance: Safety in numbers
Presented by Sarah Hall, Mipsol Limited
Description
This webinar will discuss vaccine-specific pharmacovigilance requirements in Europe during clinical development and post-authorisation. The ongoing safety assessment of the COVID vaccines will be discussed.
Vaccine Pharmacovigilance: Safety in numbers If you have any Questions about Vaccine pharmacovigilance, please submit your questions using the following link: Click Here
Programme
| 17:00 |
Opening of the Webinar |
| 17:00 |
Welcome and Introduction |
| 17:05 |
Vaccine pharmacovigilance requirements and differences from ‘standard’ pharmacovigilance
Sarah Hall, Mipsol Limited
|
| 17:40 |
Q&A Session Moderator(s): Seif Eddine Amara Madi, GSK
Sarah Hall, Mipsol Limited
|
| 18:00 |
End of the Webinar |